Question 1

Does Barclays own PLRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Barclays holds 426 shares of PLRX (Pliant Therapeutics), worth $486.

Question 2

How many shares of PLRX does Barclays own?

Accepted Answer

As of its Q2 2026 13F, Barclays holds 426 shares of PLRX (Pliant Therapeutics).

Question 3

What is Barclays' PLRX position worth?

Accepted Answer

As of its Q2 2026 13F, Barclays' PLRX position is worth $486.

Question 4

Is Barclays buying or selling PLRX?

Accepted Answer

In Q2 2026, Barclays increased its PLRX position from 34 to 426 shares.

Question 5

When did Barclays first buy PLRX?

Accepted Answer

Barclays first reported PLRX in its Q1 2022 13F and has listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	426	+1152.9%	$486	0.0%	$1.14	12
2026-Q1	Decreased	34	-99.7%	$43	0.0%	$1.26	0
2025-Q4	Decreased	10,584	-97.1%	$12,912	0.0%	$1.22	0
2025-Q3	Increased	369,556	+2767.9%	$546,943	0.0%	$1.48	39
2025-Q2	Decreased	12,886	-82.1%	$14,948	0.0%	$1.16	0
2025-Q1	Decreased	71,912	-29.4%	$97,081	0.0%	$1.35	0
2024-Q4	Decreased	101,823	-75.8%	$1.3M	0.0%	$13.17	0
2024-Q3	Increased	421,499	+22.9%	$4.7M	0.0%	$11.31	33